Jefferies cuts target, lowers EPS outlook for Cipla; flags delay in FDA approvals
Cipla#39;s largest Indian facilities including Goa and Indore are under the regulatory scanner, which could impact new launches in the medium term. It estimates the value of India business at Rs 680 per share.
Latest News from Moneycontrol.com